Targeting the ASB3-CPT1A axis—a new player in combating metabolic dysfunction-associated steatotic liver disease: Editorial on “Hepatocytic ankyrin repeat and SOCS box protein 3 deficiency alleviates metabolic dysfunction-associated steatotic liver disease by decreasing ubiquitin-mediated carnitine palmitoyltransferase 1A”

Documenti analoghi

• Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer
  di: Zheqiong Tan, et al.
  Pubblicazione: (2021-04-01)
• Effects of high-intensity intermittent training on carnitine palmitoyl transferase activity in the gastrocnemius muscle of rats
  di: L.C. Carnevali Jr, et al.
  Pubblicazione: (2012-08-01)
• Effects of high-intensity intermittent training on carnitine palmitoyl transferase activity in the gastrocnemius muscle of rats
  di: L.C. Carnevali Jr, et al.
  Pubblicazione: (2012-08-01)
• Dataset from dried blood spot acylcarnitine for detection of Carnitine-Acylcarnitine Translocase (CACT) deficiency and Carnitine Palmitoyl Transferase 2 (CPT2) deficiency
  di: Anasufiza Habib, et al.
  Pubblicazione: (2023-06-01)
• Palmitoylation controls the stability of 190 kDa ankyrin-G in dendritic spines and is regulated by ZDHHC8 and lithium
  di: Nicolas H. Piguel, et al.
  Pubblicazione: (2023-03-01)